Europe's Competition DG slams big pharma and calls for the Community patent
In what must count as one of the least surprising pieces of news ever to have come out of Brussels, the European Commission’s Competition DG has announced that its preliminary findings in an on-going investigation of the pharmaceutical industry are…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.